Edition:
India

Intellipharmaceutics International Inc (IPCI.OQ)

IPCI.OQ on NASDAQ Stock Exchange Capital Market

0.45USD
22 Jun 2018
Change (% chg)

$-0.01 (-2.58%)
Prev Close
$0.46
Open
$0.47
Day's High
$0.47
Day's Low
$0.45
Volume
33,262
Avg. Vol
48,257
52-wk High
$2.91
52-wk Low
$0.32

Chart for

About

Intellipharmaceutics International Inc is a Canada-based pharmaceutical company engaged in the research, development and manufacture of controlled-release and targeted-release oral solid dosage drugs. Its Hypermatrix technology is a multidimensional controlled-release drug delivery platform that is applied to the development of... (more)

Overall

Beta: 1.09
Market Cap(Mil.): $34.07
Shares Outstanding(Mil.): 31.02
Dividend: --
Yield (%): --

Financials

  IPCI.OQ Industry Sector
P/E (TTM): -- 30.95 32.74
EPS (TTM): -0.33 -- --
ROI: -1,305.65 14.84 14.38
ROE: -- 16.34 16.08

BRIEF-Intellipharmaceutics International Received Letter From Nasdaq To Delist Co's Securities

April 23 Intellipharmaceutics International Inc :

24 Apr 2018

BRIEF-Intellipharmaceutics Announces Us$ 1.8 mln Registered Direct Offering‍​

* INTELLIPHARMACEUTICS ANNOUNCES US$ 1.8 MILLION REGISTERED DIRECT OFFERING‍​

20 Mar 2018

BRIEF-Intellipharmaceutics Meets With FDA Regarding Oxycodone Er NDA Development Program

* INTELLIPHARMACEUTICS MEETS WITH FDA REGARDING OXYCODONE ER NDA DEVELOPMENT PROGRAM

09 Feb 2018

BRIEF-Intellipharmaceutics Provides Operational Update

* INTELLIPHARMACEUTICS - COMMERCIALIZATION OPPORTUNITIES FOR CO'S PRODUCT HAVE BEEN "CHALLENGING IN U.S. DUE TO EXTREMELY COMPETITIVE COST ENVIRONMENT"

24 Jan 2018

Competitors

  Price Chg
Merck & Co., Inc. (MRK.N) $61.47 +0.29
Novartis AG (NOVN.S) CHF75.60 +0.10
Johnson & Johnson (JNJ.N) $122.84 +1.39
Pfizer Inc. (PFE.N) $36.51 +0.21

Earnings vs. Estimates